Skip to main content

2011 to 2020 Saw Increase in Annual Prescription Meds Expenditures

Medically reviewed by Carmen Pope, BPharm. Last updated on April 16, 2024.

By Elana Gotkine HealthDay Reporter

MONDAY, April 15, 2024 -- From 2011 to 2020, there was an increase in total annual prescription medication expenditures, with antimetabolic agents the most costly category, according to a study published in the April issue of Research in Social and Administrative Pharmacy.

Whanhui Chi, from the University of Houston College of Pharmacy, and colleagues calculated the total annual medication expenditures by payer categories in a cross-sectional analysis using the 2011 to 2020 Medical Expenditures Panel Survey. Expenditures were stratified by therapeutic category. Temporal trends in medication expenditures were examined.

The researchers observed an increase in total annual prescription medication expenditures from $341.49 to $473.12 billion per year from 2011 to 2020, with the most costly category being metabolic agents. Antidiabetic agents were the most costly therapeutic area among the metabolic agents, with an increasing trend seen from $27.15 to $89.17 billion during the same period. Increasing trends in antidiabetic agent expenditure were seen for Medicare, Medicaid, TRICARE/Veterans Administration/CHAMPVA, and other sources; no trend was seen for the payer categories of out-of-pocket or other government sources. Of the antidiabetic agents, insulin had the highest expenditure.

"In light of these developments, research is needed to substantiate concerns that trends in the cost of care are outpacing patients' ability to pay," coauthor Tyler J. Varisco, Ph.D.., Pharm.D., also from the University of Houston College of Pharmacy, said in a statement. "Continuing analysis is needed to help policymakers and other key stakeholders understand how changes in practice, policy, and drug marketing converge to impact total market expenditures."

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted April 2024

Read this next

AI-Assisted Contours Superior to Cognitively Defined Prostate Cancer Contours

WEDNESDAY, July 3, 2024 -- Artificial intelligence (AI)-assisted definition of prostate cancer contours reduces underestimation of the extent of prostate cancer, according to a...

Mean Cost of Bringing New Drug to U.S. Market Is $879.3 Million

TUESDAY, July 2, 2024 -- The mean cost of developing a new drug for the U.S. market is estimated to be $879.3 million when both drug development failure and capital costs are...

Patient–Primary Care Provider Language Concordance Tied to Better Outcomes

TUESDAY, July 2, 2024 -- Patient-family physician language concordance is associated with a lower risk for adverse outcomes, according to a study published online June 3...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.